Medicare Enrolled
Dr. Renjitha Ignatius, M.D.
Medical Oncology · Sun City Center, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ignatius from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ignatius?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ignatius
Dr. Renjitha Ignatius is a medical oncology specialist in Sun City Center, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ignatius performed 218,759 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ignatius received a total of $16,864 from 99 pharmaceutical and/or device companies across 914 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ignatius is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 12% volume in FL
$16,864 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 120370 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗218,759
Medicare services
Top 12% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
73,950 | $0 | $4 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
46,200 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 22,200 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 18,460 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
16,080 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 11,820 | $18 | $51 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
7,114 | $36 | $108 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
3,828 | $26 | $116 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,771 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,716 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,262 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,730 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,290 | $95 | $339 |
| Injection, fulvestrant, 25 mg | 1,120 | $8 | $132 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
912 | $11 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
861 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 824 | $0 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
575 | $97 | $378 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
494 | $47 | $189 |
| Cyclophosphamide, 100 mg | 388 | $16 | $79 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
289 | $1 | $3 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
260 | $22 | $84 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
244 | $3 | $11 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
239 | $1 | $6 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
191 | $15 | $56 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
183 | $7 | $69 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
168 | $17 | $59 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
165 | $21 | $79 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
161 | $133 | $474 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
145 | $49 | $178 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
141 | $122 | $453 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
139 | $66 | $239 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
126 | $10 | $42 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
117 | $25 | $89 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
113 | $27 | $156 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
83 | $2 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
81 | $2 | $8 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
81 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 71 | $166 | $585 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
63 | $42 | $170 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
40 | $25 | $156 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
38 | $67 | $277 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $103 | $377 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $127 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
37.9% high complexity
58.4% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,864
Total received (2018-2024)
Avg $2,409/year across 7 years
Top 30% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
914
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,128
2023
$3,176
2022
$2,209
2021
$1,198
2020
$1,700
2019
$2,252
2018
$2,201
Payments by company (2024)
PFIZER INC.
$329
Novartis Pharmaceuticals Corporation
$294
Astellas Pharma US Inc
$247
Merck Sharp & Dohme LLC
$214
Takeda Pharmaceuticals U.S.A., Inc.
$199
E.R. Squibb & Sons, L.L.C.
$196
AstraZeneca Pharmaceuticals LP
$195
Gilead Sciences, Inc.
$167
Incyte Corporation
$143
Celgene Corporation
$133
Lilly USA, LLC
$116
ABBVIE INC.
$116
SOBI, INC
$103
Daiichi Sankyo Inc.
$100
Bayer Healthcare Pharmaceuticals Inc.
$100
Alexion Pharmaceuticals, Inc.
$97
BeiGene USA, Inc.
$96
Pharmacosmos Therapeutics Inc.
$93
Janssen Biotech, Inc.
$87
Regeneron Healthcare Solutions, Inc.
$84
Eisai Inc.
$84
Stemline Therapeutics Inc.
$79
TAIHO ONCOLOGY, INC.
$76
Genentech USA, Inc.
$69
GENZYME CORPORATION
$68
GlaxoSmithKline, LLC.
$63
JAZZ PHARMACEUTICALS INC.
$61
Exelixis Inc.
$50
Kyowa Kirin, Inc.
$42
PharmaEssentia USA Corporation
$36
Sumitomo Pharma America, Inc.
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
SERVIER PHARMACEUTICALS LLC
$32
Emmaus Medical, Inc.
$28
Blueprint Medicines Corporation
$25
Acrotech Biopharma Inc.
$25
Karyopharm Therapeutics Inc.
$24
SpringWorks Therapeutics, Inc.
$24
ARRAY BIOPHARMA INC
$23
Boston Scientific Corporation
$23
Genmab U.S., Inc.
$23
EMD Serono, Inc.
$19
Cumberland Pharmaceuticals, Inc.
$18
Mirati Therapeutics, Inc.
$17
Legend Biotech USA Inc.
$16
RECORDATI_RARE_DISEASES_INC.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Top 3 companies account for 21.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,241
PFIZER INC.
$1,034
E.R. Squibb & Sons, L.L.C.
$870
Lilly USA, LLC
$747
Merck Sharp & Dohme Corporation
$733
AstraZeneca Pharmaceuticals LP
$629
Amgen Inc.
$573
Janssen Biotech, Inc.
$567
GENZYME CORPORATION
$558
Incyte Corporation
$548
Celgene Corporation
$522
Merck Sharp & Dohme LLC
$485
Genentech USA, Inc.
$478
Daiichi Sankyo Inc.
$437
Astellas Pharma US Inc
$429
Eisai Inc.
$420
Gilead Sciences, Inc.
$323
Seagen Inc.
$290
Takeda Pharmaceuticals U.S.A., Inc.
$286
BeiGene USA, Inc.
$239
Alexion Pharmaceuticals, Inc.
$234
Exelixis Inc.
$228
Regeneron Healthcare Solutions, Inc.
$209
Bayer HealthCare Pharmaceuticals Inc.
$200
SOBI, INC
$185
Puma Biotechnology, Inc.
$173
GlaxoSmithKline, LLC.
$165
TESARO, Inc.
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Janssen Pharmaceuticals, Inc
$149
Bayer Healthcare Pharmaceuticals Inc.
$138
ABBVIE INC.
$135
EISAI INC.
$127
TerSera Therapeutics LLC
$126
Kite Pharma, Inc.
$122
Foundation Medicine, Inc.
$121
EMD Serono, Inc.
$118
Rigel Pharmaceuticals, Inc.
$117
Karyopharm Therapeutics Inc.
$108
JAZZ PHARMACEUTICALS INC.
$106
Dendreon Pharmaceuticals LLC
$103
Sirtex Medical Inc
$101
Stemline Therapeutics Inc.
$101
Pharmacosmos Therapeutics Inc.
$93
PUMA BIOTECHNOLOGY, INC.
$87
Agios Pharmaceuticals, Inc.
$83
Seattle Genetics, Inc.
$79
TAIHO ONCOLOGY, INC.
$76
Pharmacyclics LLC, An AbbVie Company
$75
Genmab U.S., Inc.
$67
Dova Pharmaceuticals
$61
AMAG Pharmaceuticals, Inc.
$56
Kyowa Kirin, Inc.
$55
SERVIER PHARMACEUTICALS LLC
$54
Blueprint Medicines Corporation
$51
AVEO Pharmaceuticals, Inc.
$51
INSYS Therapeutics Inc
$50
Sumitomo Pharma America, Inc.
$50
Acrotech Biopharma Inc.
$49
MEDIVATION FIELD SOLUTIONS LLC
$48
Mirati Therapeutics, Inc.
$46
ARRAY BIOPHARMA INC
$40
Deciphera Pharmaceuticals Inc.
$40
Alnylam Pharmaceuticals Inc.
$38
Taiho Oncology, Inc.
$37
PharmaEssentia USA Corporation
$36
Jazz Pharmaceuticals Inc.
$35
G1 Therapeutics, Inc.
$34
CTI BioPharma Corp.
$33
Sobi, Inc
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
RECORDATI_RARE_DISEASES_INC.
$31
Myovant Sciences Inc.
$29
ImmunoGen, Inc.
$29
NOVARTIS PHARMACEUTICALS CORPORATION
$28
Emmaus Medical, Inc.
$28
EUSA Pharma (US) LLC
$25
MorphoSys, US Inc.
$24
SpringWorks Therapeutics, Inc.
$24
Shire North American Group Inc
$24
TOLMAR Pharmaceuticals, Inc.
$24
Boston Scientific Corporation
$23
Apellis Pharmaceuticals, Inc.
$23
ACCORD HEALTHCARE, INC.
$23
Pharmacyclics LLC, an AbbVie Company
$23
Tolmar, Inc.
$21
Partner Therapeutics, Inc.
$19
Cumberland Pharmaceuticals, Inc.
$18
Array BioPharma Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$17
Acrotech Biopharma LLC
$16
PBG PUERTO RICO LLC
$16
Legend Biotech USA Inc.
$16
ADC Therapeutics America, Inc.
$15
Servier Pharmaceuticals LLC
$14
SECURA BIO, INC.
$14
Teva Pharmaceuticals USA, Inc.
$13
Secura Bio, Inc.
$13
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 18.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PRADAXA · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · RYZNEUTA · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Soliris · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAXOTERE · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vitrakvi · Vonjo · Vyloy · WaveWriter Alpha Prime 16 · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
59
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA SOUTH SHORE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ignatius is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ignatius experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ignatius performed 73,950 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ignatius receive payments from pharmaceutical companies?
Yes. Dr. Ignatius received a total of $16,864 from 99 companies across 914 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ignatius's costs compare to other medical oncologists in Sun City Center?
Dr. Ignatius's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ignatius) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Sun City Center
Browse medical oncologists in Sun City Center ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology